Duration of protective immunity following COVID‐19 vaccination of individuals with underlying health conditions: A rapid reviewKieran Walsh, Michelle O’Neill, Susan M. Smith et al.|Reviews in Medical Virology|2024Cited by 3
EE667 An Economic Evaluation of Herpes Zoster Vaccination With the Recombinant Vaccine for Adults in IrelandSusan Ahern, Máirín Ryan, Patricia Harrington et al.|Value in Health|2024Cited by 0
PD127 A Systematic Review Of The Clinical Effectiveness Of Recombinant Zoster Vaccine For Preventing Herpes Zoster In AdultsDavid Byrne, Máirín Ryan, Emma Reece et al.|International Journal of Technology Assessment in Health Care|2024Cited by 0
PP101 A Review Of Health State Utility Values Associated With Herpes ZosterAoife Bergin, Máirín Ryan, Helen O’Donnell et al.|International Journal of Technology Assessment in Health Care|2024Cited by 0
PP108 A Systematic Review Of Reactogenicity And Safety Of Recombinant Zoster Vaccine For Prevention Of Herpes Zoster In AdultsEmma Reece, Máirín Ryan, David Byrne et al.|International Journal of Technology Assessment in Health Care|2024Cited by 0